Therapeutic Potential of Luteolin on Cancer
Vaccines · 27.02.2023 · 11 (3) · 554
DOI: 10.3390/vaccines11030554 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 27.02.2023. Verfasst von Melisa Çetinkaya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Science, İzmir Institute of Technology, İzmir 35430, Turkey. Die Arbeit wurde bisher 141-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer is a global concern, as the rate of incidence is increasing each year. The challenges related to the current chemotherapy drugs, such as the concerns related to toxicity, turn to cancer therapeutic research to discover alternative therapy strategies that are less toxic to normal cells. Among those studies, the use of flavonoids—natural compounds produced by plants as secondary metabolites for cancer therapy—has been a hot topic in cancer treatment. Luteolin, a flavonoid that has been present in many fruits, vegetables, and herbs, has been identified to exhibit numerous biological activities, including anti-inflammatory, antidiabetic, and anticancer properties. The anticancer property of Luteolin has been extensively researched in many cancer types and has been related to its ability to inhibit tumor growth by targeting cellular processes such as apoptosis, angiogenesis, migration, and cell cycle progression. It achieves this by interacting with various signaling pathways and proteins. In the current review, the molecular targets of Luteolin as it exerts its anticancer properties, the combination therapy that includes Luteolin with other flavonoids or chemotherapeutic drugs, and the nanodelivery strategies for Luteolin are described for several cancer types.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Science, İzmir Institute of Technology, İzmir 35430, Turkey.
ORCID-Profile: Melisa Çetinkaya
Zitieren
APA
Çetinkaya, M., & Baran, Y. (2023). Therapeutic Potential of Luteolin on Cancer. Vaccines, 11(3), 554. https://doi.org/10.3390/vaccines11030554
Vancouver
Çetinkaya M, Baran Y. Therapeutic Potential of Luteolin on Cancer. Vaccines. 2023;11(3):554. doi:10.3390/vaccines11030554
BibTeX
@article{etinkaya2023,
author = {Çetinkaya, Melisa and Baran, Yusuf},
title = {Therapeutic Potential of Luteolin on Cancer},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {3},
pages = {554},
doi = {10.3390/vaccines11030554}
}
EUVIMED